Home Details
| Official Symbol of Gene | CTLA4 |
| Species | Homo sapiens |
| Entrez Gene ID | 1493 |
| Official Full Name | cytotoxic T-lymphocyte associated protein 4 |
| Also known as | CD; GSE; GRD4; ALPS5; CD152; CTLA-4; IDDM12; CELIAC3 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000163599 MIM:123890; AllianceGenome:HGNC:2505 |
| Map Location | 2q33.2 |
| Variation Type | polymorphism |
| refSNP ID | -1661 A G |
| Detected Sample | blood |
| Sample Detail | N/A |
| Detected Method | PCR |
| Disease | MS |
| Disease subtype | RRMS,PPMS |
| Population | Iranian |
| Sample Size | 153 Iranian patients and 190 healthy controls |
| Pubmed ID | 19737153 |
| Year | 2009 |
| Title | CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis |
| Risk Type | Disease risk |
| Main Result | Positive |
| Result | The distribution of -1722 T C, -1661 A G, -318 C T and +49 A G (TACA) haplotype, from the contrary, was observed to be significantly increased among controls. |
| Mechanism/Pathway | Following surface expression, CTLA4 is reported to suppress T cell function by inducing indoleamine 2,4-dioxygenase metabolism in dendritic cells. |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.